ARTD1 suppresses interleukin 6 expression by repressing MLL1- dependent histone H3 trimethylation

Molecular and Cellular Biology

Volumn 35, Issue 18, 2015, Pages 3189-3199

  Minotti, Roberta ^a   Andersson, Anneli ^a   Hottiger, Michael O ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADP RIBOSYLTRANSFERASE DIPHTHERIA TOXIN LIKE 1; ENHANCEOSOME; HISTONE H3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LYSINE; METHYLTRANSFERASE; MLL1 PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; HISTONE; HISTONE DEMETHYLASE; HISTONE LYSINE METHYLTRANSFERASE; KDM5B PROTEIN, MOUSE; MIXED LINEAGE LEUKEMIA PROTEIN; MLL PROTEIN, MOUSE; PARP1 PROTEIN, MOUSE; PHORBOL 13 ACETATE 12 MYRISTATE; RELA PROTEIN, MOUSE; SMALL INTERFERING RNA;

3T3 CELL LINE; ADENOSINE DIPHOSPHATE RIBOSYLATION; ANIMAL CELL; ARTICLE; CATALYSIS; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE REPRESSION; HISTONE METHYLATION; IN VITRO STUDY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; GENETIC TRANSCRIPTION; GENETICS; HEK293 CELL LINE; HUMAN; KNOCKOUT MOUSE; METABOLISM; METHYLATION; MOUSE; RNA INTERFERENCE;

3T3 CELLS; ANIMALS; CELL LINE; DNA-BINDING PROTEINS; HEK293 CELLS; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; INTERLEUKIN-6; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; LIPOPOLYSACCHARIDES; MACROPHAGES; METHYLATION; MICE; MICE, KNOCKOUT; MYELOID-LYMPHOID LEUKEMIA PROTEIN; POLY (ADP-RIBOSE) POLYMERASE-1; POLY(ADP-RIBOSE) POLYMERASES; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC;

EID: 84939607634     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00196-15     Document Type: Article

References (54)

1. Nishimoto N, Kishimoto T. 2006. Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol 2:619- 626. http://dx.doi.org/10.1038/ncprheum0338.
2. Ganapathi MK, Weizer AK, Borsellino S, Bukowski RM, Ganapathi R, Rice T, Casey G, Kawamura K. 1996. Resistance to interleukin 6 in human non-small cell lung carcinoma cell lines: role of receptor components. Cell Growth Differ 7:923-929.
3. Yamaji H, Iizasa T, Koh E, Suzuki M, Otsuji M, Chang H, Motohashi S, Yokoi S, Hiroshima K, Tagawa M, Nakayama T, Fujisawa T. 2004. Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer. Cancer Immunol Immunother 53:786-792.
4. Knupfer H, Preiss R. 2007. Significance of interleukin-6 (IL-6) in breast cancer. Breast Cancer Res Treat 102:129-135. http://dx.doi.org/10.1007/s10549-006-9328-3.
5. Bromberg J, Wang T. 2009. Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell 15:79-80. http://dx.doi.org/10.1016/j.ccr.2009.01.009.
6. Iliopoulos D, Hirsch HA, Wang G, Struhl K. 2011. Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL-6 secretion. Proc Natl Acad Sci U S A 108:1397-1402. http://dx.doi.org/10.1073/pnas.1018898108.
7. Hugo HJ, Lebret S, Tomaskovic-Crook E, Ahmed N, Blick T, Newgreen DF, Thompson EW, Ackland ML. 2012. Contribution of fibroblast and mast cell (afferent) and tumor (efferent) IL-6 effects within the tumor microenvironment. Cancer Microenviron 5:83-93. http://dx.doi.org/10.1007/s12307-012-0098-7.
8. Raz Y, Erez N. 2013. An inflammatory vicious cycle: fibroblasts and immune cell recruitment in cancer. Exp Cell Res 319:1596-1603. http://dx.doi.org/10.1016/j.yexcr.2013.03.022.
9. Servais C, Erez N. 2013. From sentinel cells to inflammatory culprits:cancer-associated fibroblasts in tumour-related inflammation. J Pathol 229:198-207. http://dx.doi.org/10.1002/path.4103.
10. Armenante F, Merola M, Furia A, Palmieri M. 1999. Repression of the IL-6 gene is associated with hypermethylation. Biochem Biophys Res Commun 258:644-647. http://dx.doi.org/10.1006/bbrc.1999.0566.
11. Armenante F, Merola M, Furia A, Tovey M, Palmieri M. 1999. Interleukin-6 repression is associated with a distinctive chromatin structure of the gene. Nucleic Acids Res 27:4483-4490. http://dx.doi.org/10.1093/nar/27.22.4483.
12. Dandrea M, Donadelli M, Costanzo C, Scarpa A, Palmieri M. 2009. MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines. Nucleic Acids Res 37:6681-6690. http://dx.doi.org/10.1093/nar/gkp723.
13. Takeuch O, Akira S. 2011. Epigenetic control of macrophage polarization. Eur J Immunol 41:2490-2493. http://dx.doi.org/10.1002/eji.201141792.
14. Tang B, Zhao R, Sun Y, Zhu Y, Zhong J, Zhao G, Zhu N. 2011. Interleukin-6 expression was regulated by epigenetic mechanisms in response to influenza virus infection or dsRNA treatment. Mol Immunol 48:1001-1008. http://dx.doi.org/10.1016/j.molimm.2011.01.003.
15. Li Q, Verma IM. 2002. NF-_B regulation in the immune system. Nat Rev Immunol 2:725-734. http://dx.doi.org/10.1038/nri910.
16. Karin M, Greten FR. 2005. NF-_B: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749-759. http://dx.doi.org/10.1038/nri1703.
17. Tak PP, Firestein GS. 2001. NF-_B: a key role in inflammatory diseases. J Clin Invest 107:7-11. http://dx.doi.org/10.1172/JCI11830.
18. Hassa PO, Haenni SS, Buerki C, Meier NI, Lane WS, Owen H, Gersbach M, Imhof R, Hottiger MO. 2005. Acetylation of poly(ADP-ribose) polymerase-1 by p300/CREB-binding protein regulates coactivation of NF-_B-dependent transcription. J Biol Chem 280:40450-40464. http://dx.doi.org/10.1074/jbc.M507553200.
19. Mao X, Gluck N, Li D, Maine GN, Li H, Zaidi IW, Repaka A, Mayo MW, Burstein E. 2009. GCN5 is a required cofactor for a ubiquitin ligase that targets NF-_B/RelA. Genes Dev 23:849-861. http://dx.doi.org/10.1101/gad.1748409.
20. Smale ST. 2010. Selective transcription in response to an inflammatory stimulus. Cell 140:833-844. http://dx.doi.org/10.1016/j.cell.2010.01.037.
21. Li H, Wittwer T, Weber A, Schneider H, Moreno R, Maine GN, Kracht M, Schmitz ML, Burstein E. 2012. Regulation of NF-_B activity by competition between RelA acetylation and ubiquitination. Oncogene 31:611-623. http://dx.doi.org/10.1038/onc.2011.253.
22. Sen N, Paul BD, Gadalla MM, Mustafa AK, Sen T, Xu R, Kim S, Snyder SH. 2012. Hydrogen sulfide-linked sulfhydration of NF-_B mediates its antiapoptotic actions. Mol Cell 45:13-24. http://dx.doi.org/10.1016/j.molcel.2011.10.021.
23. Ansari KI, Mandal SS. 2010. Mixed lineage leukemia: roles in gene expression, hormone signaling and mRNA processing. FEBS J 277:1790-1804. http://dx.doi.org/10.1111/j.1742-4658.2010.07606.x.
24. Hubert A, Henderson JM, Ross KG, Cowles MW, Torres J, Zayas RM. 2013. Epigenetic regulation of planarian stem cells by the SET1/MLL family of histone methyltransferases. Epigenetics 8:79-91. http://dx.doi.org/10.4161/epi.23211.
25. Wang X, Zhu K, Li S, Liao Y, Du R, Zhang X, Shu HB, Guo AY, Li L, Wu M. 2012. MLL1, a H3K4 methyltransferase, regulates the TNF_- stimulated activation of genes downstream of NF-_B. J Cell Sci 125:4058-4066. http://dx.doi.org/10.1242/jcs.103531.
26. Marschalek R. 2010. Mixed lineage leukemia: roles in human malignancies and potential therapy. FEBS J 277:1822-1831. http://dx.doi.org/10.1111/j.1742-4658.2010.07608.x.
27. Zhang P, Bergamin E, Couture JF. 2013. The many facets of MLL1 regulation. Biopolymers 99:136-145. http://dx.doi.org/10.1002/bip.22126.
28. Ramirez-Carrozzi V, Braas D, Bhatt D, Cheng C, Hong C, Doty K, Black J, Hoffmann A, Carey M, Smale S. 2009. A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 138:114-128. http://dx.doi.org/10.1016/j.cell.2009.04.020.
29. Iliopoulos D, Hirsch H, Struhl K. 2009. An epigenetic switch involving NF-_B, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139:693-706. http://dx.doi.org/10.1016/j.cell.2009.10.014.
30. Korkaya H, Liu S, Wicha MS. 2011. Regulation of cancer stem cells by cytokine networks: attacking cancer's inflammatory roots. Clin Cancer Res 17:6125-6129. http://dx.doi.org/10.1158/1078-0432.CCR-10-2743.
31. Kraus WL, Hottiger MO. 2013. PARP-1 and gene regulation: progress and puzzles. Mol Aspects Med 34:1109-1123. http://dx.doi.org/10.1016/j.mam.2013.01.005.
32. Rosenthal F, Hottiger MO. 2014. Identification of ADP-ribosylated peptides and ADP-ribose acceptor sites. Front Biosci (Landmark ed) 19:1041-1056. http://dx.doi.org/10.2741/4266.
33. Elser M, Borsig L, Hassa PO, Erener S, Messner S, Valovka T, Keller S, Gassmann M, Hottiger MO. 2008. Poly(ADP-ribose) polymerase 1 promotes tumor cell survival by coactivating hypoxia-inducible factor-1- dependent gene expression. Mol Cancer Res 6:282-290. http://dx.doi.org/10.1158/1541-7786.MCR-07-0377.
34. D'Amours D, Desnoyers S, D'Silva I, Poirier G. 1999. Poly(ADPribosyl) ation reactions in the regulation of nuclear functions. Biochem J 342:249-268. http://dx.doi.org/10.1042/0264-6021:3420249.
35. Kraus W, Lis J. 2003. PARP goes transcription. Cell 113:677-683. http://dx.doi.org/10.1016/S0092-8674(03)00433-1.
36. de Murcia G, Huletsky A, Lamarre D, Gaudreau A, Pouyet J, Daune M, Poirier G. 1986. Modulation of chromatin superstructure induced by poly(ADP-ribose) synthesis and degradation. J Biol Chem 261:7011-7017.
37. Kim M, Mauro S, Gévry N, Lis J, Kraus W. 2004. NAD_-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1. Cell 119:803-814. http://dx.doi.org/10.1016/j.cell.2004.11.002.
38. Krishnakumar R, Gamble M, Frizzell K, Berrocal J, Kininis M, Kraus W. 2008. Reciprocal binding of PARP-1 and histone H1 at promoters specifies transcriptional outcomes. Science 319:819-821. http://dx.doi.org/10.1126/science.1149250.
39. Altmeyer M, Messner S, Hassa PO, Fey M, Hottiger MO. 2009. Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites. Nucleic Acids Res 37:3723-3738. http://dx.doi.org/10.1093/nar/gkp229.
40. Messner S, Altmeyer M, Zhao H, Pozivil A, Roschitzki B, Gehrig P, Rutishauser D, Huang D, Caflisch A, Hottiger MO. 2010. PARP1 ADPribosylates lysine residues of the core histone tails. Nucleic Acids Res 38:6350-6362. http://dx.doi.org/10.1093/nar/gkq463.
41. Ahel D, Horejsi Z, Wiechens N, Polo SE, Garcia-Wilson E, Ahel I, Flynn H, Skehel M, West SC, Jackson SP, Owen-Hughes T, Boulton SJ. 2009. Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science 325:1240-1243. http://dx.doi.org/10.1126/science.1177321.
42. Gottschalk A, Timinszky G, Kong S, Jin J, Cai Y, Swanson S, Washburn M, Florens L, Ladurner A, Conaway J, Conaway R. 2009. Poly(ADPribosyl) ation directs recruitment and activation of an ATP-dependent chromatin remodeler. Proc Natl Acad Sci U S A 106:13770-13774. http://dx.doi.org/10.1073/pnas.0906920106.
43. Krishnakumar R, Kraus W. 2010. PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. Mol Cell 39:736-749. http://dx.doi.org/10.1016/j.molcel.2010.08.014.
44. Hassa PO, Hottiger MO. 1999. A role of poly (ADP-ribose) polymerase in NF-_B transcriptional activation. Biol Chem 380:953-959.
45. Hassa PO, Buerki C, Lombardi C, Imhof R, Hottiger MO. 2003. Transcriptional coactivation of nuclear factor-_B-dependent gene expression by p300 is regulated by poly(ADP)-ribose polymerase-1. J Biol Chem 278:45145-45153. http://dx.doi.org/10.1074/jbc.M307957200.
46. Hassa PO, Covic M, Bedford MT, Hottiger MO. 2008. Protein arginine methyltransferase 1 coactivates NF-_B-dependent gene expression synergistically with CARM1 and PARP1. J Mol Biol 377:668-678. http://dx.doi.org/10.1016/j.jmb.2008.01.044.
47. Hassa PO, Covic M, Hasan S, Imhof R, Hottiger MO. 2001. The enzymatic and DNA binding activity of PARP-1 are not required for NF-_B coactivator function. J Biol Chem 276:45588-45597. http://dx.doi.org/10.1074/jbc.M106528200.
48. von Lukowicz T, Hassa PO, Lohmann C, Borén J, Braunersreuther V, Mach F, Odermatt B, Gersbach M, Camici GG, Stähli BE, Tanner FC, Hottiger MO, Lüscher TF, Matter CM. 2008. PARP1 is required for adhesion molecule expression in atherogenesis. Cardiovasc Res 78:158-166. http://dx.doi.org/10.1093/cvr/cvm110.
49. Erener S, Petrilli V, Kassner I, Minotti R, Castillo R, Santoro R, Hassa PO, Tschopp J, Hottiger MO. 2012. Inflammasome-activated caspase 7 cleaves PARP1 to enhance the expression of a subset of NF-_B target genes. Mol Cell 46:200-211. http://dx.doi.org/10.1016/j.molcel.2012.02.016.
50. Saccani S, Pantano S, Natoli G. 2001. Two waves of nuclear factor _B recruitment to target promoters. J Exp Med 193:1351-1359. http://dx.doi.org/10.1084/jem.193.12.1351.
51. Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T. 2001. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410:116-120. http://dx.doi.org/10.1038/35065132.
52. Santos-Rosa H, Schneider R, Bannister AJ, Sherriff J, Bernstein BE, Emre NC, Schreiber SL, Mellor J, Kouzarides T. 2002. Active genes are tri-methylated at K4 of histone H3. Nature 419:407-411. http://dx.doi.org/10.1038/nature01080.
53. Wacker D, Ruhl D, Balagamwala E, Hope K, Zhang T, Kraus W. 2007. TheDNAbinding and catalytic domains of poly(ADP-ribose) polymerase 1 cooperate in the regulation of chromatin structure and transcription. Mol Cell Biol 27:7475-7485. http://dx.doi.org/10.1128/MCB.01314-07.
54. Santoro R, Li J, Grummt I. 2002. The nucleolar remodeling complex NoRC mediates heterochromatin formation and silencing of ribosomal gene transcription. Nat Genet 32:393-396. http://dx.doi.org/10.1038/ng1010.